会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 73. 发明申请
    • ELECTROPHYSIOLOGICAL DEVICE
    • 电生理装置
    • WO1997008988A1
    • 1997-03-13
    • PCT/FR1996001351
    • 1996-09-04
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUERIPOCHE, AndréBAUDONNIERE, Pierre-Marie
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    • A61B05/04
    • A61B5/04004A61B5/0428
    • A sensor equipment (1) to be fitted to a subject has a set of electrodes (2-4) for detecting electromagnetic signals and delivering them as output signals to processing means (6) for shaping said signals prior to the storage thereof. The set of electrodes includes working electrodes having one or more acquisition electrodes (3) as well as a secondary electrode (4) to be connected to the processing means as a floating mass. The output of at least each working electrode is provided with an impedance adapter means (AO2, AO3). The device further comprises a common power supply (10) for said impedance adapter means, as well as a circuit (14) for maintaining an intermediate electric potential, connected to said supply (10), at the electric potential of the secondary electrode (E4).
    • 要安装到被摄体的传感器设备(1)具有用于检测电磁信号的一组电极(2-4),并将它们作为输出信号传送到处理装置(6),用于在存储之前对所述信号进行整形。 电极组包括具有一个或多个采集电极(3)的工作电极以及作为浮动质量块连接到处理装置的次级电极(4)。 至少每个工作电极的输出端设有阻抗适配器装置(AO2,AO3)。 该装置还包括用于所述阻抗适配器装置的公共电源(10),以及用于在辅助电极(E4)的电位处连接到所述电源(10)的用于维持中间电位的电路(14) )。
    • 76. 发明申请
    • NUCLEOTIDE AND PEPTIDE SEQUENCES FOR TREATING MYASTHENIA
    • 用于治疗MYASTHENIA的核苷酸和肽段序列
    • WO1997004093A1
    • 1997-02-06
    • PCT/FR1996001131
    • 1996-07-18
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUECOHEN-KAMINSKY, SylviaBERRIH-AKNIN, Sonia
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    • C12N15/12
    • C07K16/2809A61K39/00A61K2039/51C07K14/7051
    • The use of nucleotide or peptide sequences for preparing drugs suitable for treating or preventing acquired auto-immune myasthenia is disclosed. Said nucleotide sequences are selected from sequences capable of coding for a peptide sequence that is in turn capable of causing the formation of antibodies that recognise and form an immunological complex with all or part of the amino acid sequence of human T cell receptor segment V beta 5.1; or sequences capable of coding for a peptide sequence that itself represents an antibody capable of recognising and forming an immunological complex with all or part of the amino acid sequence of said segment V beta 5.1; sequences capable of coding for an anti-sense RNA that is in turn capable of hybridising with all or part of the mRNA coded for by the DNA sequence coding for the amino acid sequence of said segment V beta 5.1; or sequences capable of hybridising with all or part of the DNA sequence coding for the amino acid sequence of said segment V beta 5.1, or with all or part of the mRNA coded for by said DNA sequence. Said peptide sequences are selected from sequences capable of causing the formation of antibodies that recognise and form an immunological complex with human T cell receptor segment V beta 5.1; or sequences corresponding to antibodies capable of recognising and forming an immunological complex with all or part of the amino acid sequence of T cell receptor segment V beta 5.1.
    • 公开了使用核苷酸或肽序列制备适于治疗或预防所获得的自身免疫性重症肌无力的药物。 所述核苷酸序列选自能够编码肽序列的序列,所述肽序列又能够导致形成识别并与人T细胞受体区段Vβ15.1的全部或部分氨基酸序列形成免疫复合物的抗体 ; 或能够编码肽序列的序列,其本身表示能够识别并与所述片段Vβ15.1的全部或部分氨基酸序列形成免疫复合物的抗体; 能够编码反义RNA的序列,其又能够与编码所述片段Vβ15.1的氨基酸序列的DNA序列编码的全部或部分mRNA杂交; 或能够与编码所述区段V beta 5.1的氨基酸序列的全部或部分DNA序列杂交的序列,或与所述DNA序列编码的全部或部分mRNA相互杂交的序列。 所述肽序列选自能够形成识别并与人T细胞受体区段Vβ15.1形成免疫复合物的抗体的序列; 或对应于能够识别T细胞受体区段V beta 5.1的全部或部分氨基酸序列的免疫复合物的抗体的序列。
    • 79. 发明申请
    • DEVICE FOR CONTROLLING EYE MOVEMENT
    • 用于控制眼睛运动的装置
    • WO1995031927A1
    • 1995-11-30
    • PCT/FR1995000627
    • 1995-05-15
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUEJOUEN, FrançoisBAUDONNIERE, Pierre-Marie
    • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    • A61B03/113
    • A61B3/113
    • A support (12) for a living being, controllably movable in three directions, defines an area (29-I) for the eyes (30-I). A frame (1) comprises two light sources (14), supplying, at the level of the area (29-I) for the eyes (30-I), two infrared light beams (37-I), two cameras (13-I), each for capturing an image derived from the reflection of said light beam (37-I) on an eye (30-I) and processing means for digitalizing the eye images and processing them in real time to calculate the center coordinates of the corneal point (42-I) with reference to the pupil center (41-I). The processing means further control the movement of the support (12) to position the eyes (30-I) precisely in the axis of the cameras (13-I), according to the coordinates of the pupil contour. A mass memory in the microcomputer (2) stores the data relating to a plurality of basic visual tests comprising a selected sequence of visual stimulation images. The response of the eyes to an image provides a gaze direction which is analyzed by processing means.
    • 用于生物体的支撑件(12)可在三个方向上可控地移动,限定了眼睛(30-I)的区域(29-I)。 框架(1)包括两个光源(14),在眼睛(30-I)的区域(29-I)的水平处提供两个红外光束(37-I),两个照相机 I),每个用于捕获从眼睛(30-I)上的所述光束(37-I)的反射导出的图像和用于数字化眼睛图像并且实时处理它们的处理装置,以计算中心坐标 参照瞳孔中心(41-I)的角膜点(42-I)。 处理装置还根据瞳孔轮廓的坐标进一步控制支撑件(12)的移动以将眼睛(30-I)精确地定位在照相机(13-I)的轴线上。 微型计算机(2)中的大容量存储器存储与包括所选择的视觉刺激图像序列的多个基本视觉测试有关的数据。 眼睛对图像的响应提供了通过处理手段分析的注视方向。